GridAI Technologies Corp. Total Liabilities
GridAI Technologies Corp. total liabilities. Based on the latest financial reports, GridAI Technologies Corp. (GRDX) has total liabilities worth $18.27 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check GridAI Technologies Corp. liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of GridAI Technologies Corp. (2013–2025)
Total liabilities of GridAI Technologies Corp. from 2013 to 2025. This chart illustrates how GridAI Technologies Corp.'s total liabilities have evolved over time, based on quarterly financial data.
GridAI Technologies Corp. Competitors by Total Liabilities
The table below lists competitors of GridAI Technologies Corp. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Newtree S.A
BR:NEWT
|
Belgium | €697.20K |
|
Gabungan AQRS Bhd
KLSE:5226
|
Malaysia | RM882.57 Million |
|
UTSTARCOM HLDGS DL-0015
F:UT5
|
Germany | €19.41 Million |
|
Plantynet Co. Ltd
KQ:075130
|
Korea | ₩13.74 Billion |
|
Trimegah Karya Pratama Tbk PT
JK:UVCR
|
Indonesia | Rp113.41 Billion |
|
Flexiroam Ltd
AU:FRX
|
Australia | AU$5.46 Million |
|
S&K Polytec Co. Ltd
KQ:091340
|
Korea | ₩132.20 Billion |
|
Perpetuals.com Ltd
NASDAQ:PDC
|
USA | $19.53 Million |
Liability Composition Analysis (2013–2025)
This chart breaks down GridAI Technologies Corp.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see GRDX total asset value.
Liquidity & Leverage Metrics
GridAI Technologies Corp. Total Liabilities Ratios Explained
GridAI Technologies Corp. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.44 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how GridAI Technologies Corp.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for GridAI Technologies Corp. (2013–2025)
The table below shows the annual total liabilities of GridAI Technologies Corp. from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $19.72 Million | -28.57% |
| 2024-12-31 | $27.61 Million | +741.55% |
| 2023-12-31 | $3.28 Million | +21.60% |
| 2022-12-31 | $2.70 Million | -86.25% |
| 2021-12-31 | $19.61 Million | +26.00% |
| 2020-12-31 | $15.56 Million | +263.18% |
| 2019-12-31 | $4.29 Million | +43.07% |
| 2018-12-31 | $3.00 Million | -21.56% |
| 2017-12-31 | $3.82 Million | +7.86% |
| 2016-12-31 | $3.54 Million | -65.67% |
| 2015-12-31 | $10.32 Million | +162.42% |
| 2014-12-31 | $3.93 Million | +318.49% |
| 2013-12-31 | $939.30K | -- |
About GridAI Technologies Corp.
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in … Read more